Clinical impact of a pharmacist-physician co-managed programme on hyperlipidaemia management in Hong Kong

Summary Objective: The study aimed to investigate the clinical impact of pharmacist–physician co‐managed programme on the management of hyperlipidaemia. Methods: The study was a prospective randomized controlled trial. Adult patients were selected if: (i) they were taking one or more lipid‐lowerin...

Celý popis

Uloženo v:

Podrobná bibliografie
Vydáno v:	Journal of clinical pharmacy and therapeutics Ročník 34; číslo 4; s. 407 - 414
Hlavní autoři:	Lee, V. W. Y., Fan, C. S. Y., Li, A. W. M., Chau, A. C. Y.
Médium:	Journal Article
Jazyk:	angličtina
Vydáno:	Oxford, UK Blackwell Publishing Ltd 01.08.2009 Blackwell
Témata:	Aged Biological and medical sciences Cholesterol - blood cholesterol management Cholesterol, LDL - blood Cholesterol, LDL - drug effects clinical pharmacy Disorders of blood lipids. Hyperlipoproteinemia Female Follow-Up Studies Hong Kong Humans Hyperlipidemias - drug therapy Hypolipidemic Agents - therapeutic use Interprofessional Relations Life Style Male Medical sciences Metabolic diseases Middle Aged Pharmaceutical Services - organization & administration Pharmacists - organization & administration Pharmacology. Drug treatments Physicians - organization & administration Professional Role Prospective Studies Single-Blind Method Hong Kong Asia China clinical pharmacy Clinical management Health staff cholesterol management Chemist Physician Metabolic diseases Lipids Hyperlipemia Dyslipemia Cholesterol Hospital pharmacy
ISSN:	0269-4727, 1365-2710, 1365-2710
On-line přístup:	Získat plný text
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!

Abstract	Summary Objective: The study aimed to investigate the clinical impact of pharmacist–physician co‐managed programme on the management of hyperlipidaemia. Methods: The study was a prospective randomized controlled trial. Adult patients were selected if: (i) they were taking one or more lipid‐lowering agents with a valid lipid panel before their next follow up; (ii) had a baseline lipid profile within the previous 6 months; (iii) their lipid panel did not reach the targeted low‐density lipoprotein‐cholesterol (LDL‐C) goal based on the National Cholesterol Education Programme Adult Treatment Panel III. Pharmacists interviewed patients in the intervention group for 15–30 min to provide consultation on the drug regimen and lifestyle modifications. A telephone follow‐up every 4 weeks and a follow‐up interview on the date of the physician visit were scheduled. Patients in the control group received routine conventional care. The primary outcome measurement was the change in lipid panel between baseline and at the end of study. Results: One hundred and eighteen patients were recruited to the study [58 patients in intervention group (mean age 63 ± 10 years old) and 60 in control group (mean age 61 ± 12 years old)]. Starting with similar baseline levels, the end of study LDL‐C and total cholesterol levels for the intervention and control groups were LDL‐C: 2·80 ± 0·89 mmol/L and total cholesterol 4·75 ± 1·08 mmol/L vs. LDL‐C: 3·24 ± 0·78 mmol/L and total cholesterol 5·18 ± 0·93 mmol/L, respectively. The differences were statistically significant (P < 0·0015). Conclusion: The study showed that a pharmacist–physician co‐managed programme for hyperlipidaemic patient was effective in getting more patients to reach their target lipid levels.
AbstractList	Summary Objective: The study aimed to investigate the clinical impact of pharmacist–physician co‐managed programme on the management of hyperlipidaemia. Methods: The study was a prospective randomized controlled trial. Adult patients were selected if: (i) they were taking one or more lipid‐lowering agents with a valid lipid panel before their next follow up; (ii) had a baseline lipid profile within the previous 6 months; (iii) their lipid panel did not reach the targeted low‐density lipoprotein‐cholesterol (LDL‐C) goal based on the National Cholesterol Education Programme Adult Treatment Panel III. Pharmacists interviewed patients in the intervention group for 15–30 min to provide consultation on the drug regimen and lifestyle modifications. A telephone follow‐up every 4 weeks and a follow‐up interview on the date of the physician visit were scheduled. Patients in the control group received routine conventional care. The primary outcome measurement was the change in lipid panel between baseline and at the end of study. Results: One hundred and eighteen patients were recruited to the study [58 patients in intervention group (mean age 63 ± 10 years old) and 60 in control group (mean age 61 ± 12 years old)]. Starting with similar baseline levels, the end of study LDL‐C and total cholesterol levels for the intervention and control groups were LDL‐C: 2·80 ± 0·89 mmol/L and total cholesterol 4·75 ± 1·08 mmol/L vs. LDL‐C: 3·24 ± 0·78 mmol/L and total cholesterol 5·18 ± 0·93 mmol/L, respectively. The differences were statistically significant (P < 0·0015). Conclusion: The study showed that a pharmacist–physician co‐managed programme for hyperlipidaemic patient was effective in getting more patients to reach their target lipid levels. The study aimed to investigate the clinical impact of pharmacist-physician co-managed programme on the management of hyperlipidaemia. The study was a prospective randomized controlled trial. Adult patients were selected if: (i) they were taking one or more lipid-lowering agents with a valid lipid panel before their next follow up; (ii) had a baseline lipid profile within the previous 6 months; (iii) their lipid panel did not reach the targeted low-density lipoprotein-cholesterol (LDL-C) goal based on the National Cholesterol Education Programme Adult Treatment Panel III. Pharmacists interviewed patients in the intervention group for 15-30 min to provide consultation on the drug regimen and lifestyle modifications. A telephone follow-up every 4 weeks and a follow-up interview on the date of the physician visit were scheduled. Patients in the control group received routine conventional care. The primary outcome measurement was the change in lipid panel between baseline and at the end of study. One hundred and eighteen patients were recruited to the study [58 patients in intervention group (mean age 63 +/- 10 years old) and 60 in control group (mean age 61 +/- 12 years old)]. Starting with similar baseline levels, the end of study LDL-C and total cholesterol levels for the intervention and control groups were LDL-C: 2.80 +/- 0.89 mmol/L and total cholesterol 4.75 +/- 1.08 mmol/L vs. LDL-C: 3.24 +/- 0.78 mmol/L and total cholesterol 5.18 +/- 0.93 mmol/L, respectively. The differences were statistically significant (P < 0.0015). The study showed that a pharmacist-physician co-managed programme for hyperlipidaemic patient was effective in getting more patients to reach their target lipid levels. The study aimed to investigate the clinical impact of pharmacist-physician co-managed programme on the management of hyperlipidaemia.OBJECTIVEThe study aimed to investigate the clinical impact of pharmacist-physician co-managed programme on the management of hyperlipidaemia.The study was a prospective randomized controlled trial. Adult patients were selected if: (i) they were taking one or more lipid-lowering agents with a valid lipid panel before their next follow up; (ii) had a baseline lipid profile within the previous 6 months; (iii) their lipid panel did not reach the targeted low-density lipoprotein-cholesterol (LDL-C) goal based on the National Cholesterol Education Programme Adult Treatment Panel III. Pharmacists interviewed patients in the intervention group for 15-30 min to provide consultation on the drug regimen and lifestyle modifications. A telephone follow-up every 4 weeks and a follow-up interview on the date of the physician visit were scheduled. Patients in the control group received routine conventional care. The primary outcome measurement was the change in lipid panel between baseline and at the end of study.METHODSThe study was a prospective randomized controlled trial. Adult patients were selected if: (i) they were taking one or more lipid-lowering agents with a valid lipid panel before their next follow up; (ii) had a baseline lipid profile within the previous 6 months; (iii) their lipid panel did not reach the targeted low-density lipoprotein-cholesterol (LDL-C) goal based on the National Cholesterol Education Programme Adult Treatment Panel III. Pharmacists interviewed patients in the intervention group for 15-30 min to provide consultation on the drug regimen and lifestyle modifications. A telephone follow-up every 4 weeks and a follow-up interview on the date of the physician visit were scheduled. Patients in the control group received routine conventional care. The primary outcome measurement was the change in lipid panel between baseline and at the end of study.One hundred and eighteen patients were recruited to the study [58 patients in intervention group (mean age 63 +/- 10 years old) and 60 in control group (mean age 61 +/- 12 years old)]. Starting with similar baseline levels, the end of study LDL-C and total cholesterol levels for the intervention and control groups were LDL-C: 2.80 +/- 0.89 mmol/L and total cholesterol 4.75 +/- 1.08 mmol/L vs. LDL-C: 3.24 +/- 0.78 mmol/L and total cholesterol 5.18 +/- 0.93 mmol/L, respectively. The differences were statistically significant (P < 0.0015).RESULTSOne hundred and eighteen patients were recruited to the study [58 patients in intervention group (mean age 63 +/- 10 years old) and 60 in control group (mean age 61 +/- 12 years old)]. Starting with similar baseline levels, the end of study LDL-C and total cholesterol levels for the intervention and control groups were LDL-C: 2.80 +/- 0.89 mmol/L and total cholesterol 4.75 +/- 1.08 mmol/L vs. LDL-C: 3.24 +/- 0.78 mmol/L and total cholesterol 5.18 +/- 0.93 mmol/L, respectively. The differences were statistically significant (P < 0.0015).The study showed that a pharmacist-physician co-managed programme for hyperlipidaemic patient was effective in getting more patients to reach their target lipid levels.CONCLUSIONThe study showed that a pharmacist-physician co-managed programme for hyperlipidaemic patient was effective in getting more patients to reach their target lipid levels.
Author	Chau, A. C. Y. Fan, C. S. Y. Lee, V. W. Y. Li, A. W. M.
Author_xml	– sequence: 1 givenname: V. W. Y. surname: Lee fullname: Lee, V. W. Y. organization: School of Pharmacy, Faculty of Medicine, The Chinese University of Hong Kong – sequence: 2 givenname: C. S. Y. surname: Fan fullname: Fan, C. S. Y. organization: North District Hospital, Hospital Authority – sequence: 3 givenname: A. W. M. surname: Li fullname: Li, A. W. M. organization: Prince of Wales Hospital, Hospital Authority – sequence: 4 givenname: A. C. Y. surname: Chau fullname: Chau, A. C. Y. organization: Our lady of Maryknoll Hosptial, Hospital Authority, Hong Kong
BackLink	http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21984180$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/19583673$$D View this record in MEDLINE/PubMed
BookMark	eNqNkUtz0zAUhTVMGZq2_AVGG9g56GXL3jADoQ9Kp3RRBnaaa1tKFCzZSM40-ffIJGTBBrTQ87tHd845Qye-9xohTMmcpvF2Pae8yDMm0wUjpJoTSpiYb5-h2fHhBM0IK6pMSCZP0VmMa0JIIRl_gU5plZe8kHyG7KKz3jbQYesGaEbcGwx4WEFw0Ng4ZsNqF21jweOmzxx4WOoWD6FfBnBO497j1W7QobODbUE7C3gPOe1HbD2-6f0Sf07TBXpuoIv65WE9R1-vLh8XN9ndl-tPi_d3WSN4IbK2LjQrDZcgWJXnrRatocIYlqdDXRlRsJpwQ6CiLec1M7KWPEHAKDO1yfk5erPXTU3-3Og4Kmdjo7sOvO43URVSFDnLaQJfHcBN7XSrhmAdhJ36Y04CXh8AiMkhE8AnS44co1UpaEkS927PNaGPMWijGjvCaHs_BrCdokRNqam1msJRUzhqSk39Tk1tk0D5l8Cxl3-XHv5-sp3e_Xedul08PE7bJJDtBVLYensUgPAjOcVlrr7dX6sr8eH7ffXxNqn9Aq5Cvl0
CitedBy_id	crossref_primary_10_1016_j_sapharm_2017_06_008 crossref_primary_10_1007_s11096_011_9479_0 crossref_primary_10_1161_JAHA_119_013627 crossref_primary_10_1016_j_jacl_2020_04_004 crossref_primary_10_1016_j_clinthera_2017_10_009 crossref_primary_10_1186_s12872_015_0117_y crossref_primary_10_3390_pharmacy5020028
Cites_doi	10.1161/01.CIR.0000157730.94423.4B 10.1056/NEJM199811053391902 10.1592/phco.20.5.410.35048 10.1001/jama.296.21.jed60074 10.1001/jama.288.4.455 10.1001/archinte.165.1.49 10.4278/0890-1171-12.1.38 10.2165/00115677-200513040-00006 10.1161/01.CIR.83.4.1294 10.1161/01.CIR.0000133317.49796.0E 10.1177/0091270004265364 10.1001/jama.279.18.1458 10.1001/archfami.9.10.1169 10.1016/j.atherosclerosis.2005.05.013 10.1111/j.1524-4733.2008.00372.x 10.1136/bmj.38905.447118.2F 10.2165/00115677-200614040-00005 10.2146/ajhp050543 10.1161/circ.106.25.3143 10.1046/j.1365-2796.1997.112133000.x 10.1592/phco.20.17.1375.34895 10.2146/ajhp060056 10.2165/00019053-200725010-00004
ContentType	Journal Article
Copyright	2009 The Authors. Journal compilation © 2009 Blackwell Publishing Ltd 2009 INIST-CNRS
Copyright_xml	– notice: 2009 The Authors. Journal compilation © 2009 Blackwell Publishing Ltd – notice: 2009 INIST-CNRS
DBID	BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8
DOI	10.1111/j.1365-2710.2009.01024.x
DatabaseName	Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic
DatabaseTitle	CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic
DatabaseTitleList	MEDLINE MEDLINE - Academic
Database_xml	– sequence: 1 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: 7X8 name: MEDLINE - Academic url: https://search.proquest.com/medline sourceTypes: Aggregation Database
DeliveryMethod	fulltext_linktorsrc
Discipline	Pharmacy, Therapeutics, & Pharmacology
EISSN	1365-2710
EndPage	414
ExternalDocumentID	19583673 21984180 10_1111_j_1365_2710_2009_01024_x JCPT1024 ark_67375_WNG_F4BXN9DJ_1
Genre	article Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article
GeographicLocations	Hong Kong Asia China
GeographicLocations_xml	– name: Hong Kong
GroupedDBID	--- .3N .GA .Y3 04C 05W 0R~ 10A 1CY 1OB 1OC 24P 29K 31~ 33P 36B 3SF 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5HH 5LA 5RE 5VS 66C 6PF 702 7PT 7X7 8-0 8-1 8-3 8-4 8-5 8FI 8FJ 8UM 930 A01 A03 AAESR AAEVG AAFWJ AAKAS AAMMB AANHP AAONW AASGY AAWTL AAXRX AAZKR ABCQN ABCUV ABDBF ABEML ABIVO ABJNI ABPVW ABUWG ABXGK ACAHQ ACBWZ ACCMX ACCZN ACFBH ACGFO ACGFS ACIWK ACMXC ACPOU ACPRK ACRPL ACSCC ACUHS ACXBN ACXQS ACYXJ ADBBV ADEOM ADIZJ ADKYN ADMGS ADNMO ADOJX ADOZA ADXAS ADZCM ADZMN AEFGJ AEGXH AEIMD AENEX AFBPY AFEBI AFGKR AFKRA AFRAH AFZJQ AGQPQ AGXDD AHEFC AHMBA AIACR AIAGR AIDQK AIDYY AIQQE AIURR ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ATUGU AZBYB AZFZN AZVAB BAFTC BDRZF BENPR BFHJK BHBCM BMSDO BMXJE BROTX BRXPI BSCLL BY8 C45 CAG CCPQU COF CS3 D-6 D-7 D-E D-F D-I DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EAD EAP EAS EBB EBC EBD EBS EBX ECF ECT ECV EIHBH EJD EMB EMK EMOBN ENC ENX EPT ESX EX3 F00 F5P FEDTE FUBAC FYUFA FZ0 G-S G.N GODZA GWYGA H.X HF~ HMCUK HVGLF HZI HZ~ IHE IX1 J0M K48 KBYEO LATKE LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LSO LUTES LW6 LYRES MK0 MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ O66 O9- OIG OVD P2P P2W P2X P2Z P4B P4D PALCI PHGZM PHGZT PIMPY PQQKQ PUEGO Q.N Q11 QB0 Q~Q R.K RIWAO RJQFR ROL RX1 SAMSI SUPJJ SV3 TEORI TUS UB1 UKHRP V8K W8V W99 WBKPD WH7 WHWMO WIH WIJ WIK WOHZO WOW WQ9 WQJ WVDHM WXI WXSBR XG1 YFH YOC YUY ZGI ZZTAW ~IA ~WT AAHHS AAJEY ACCFJ AEEZP AEQDE AEUQT AFPWT AIWBW AJBDE ALIPV RHX WUP YCJ AAYXX AFFHD CITATION O8X IQODW CGR CUY CVF ECM EIF NPM 7X8
ID	FETCH-LOGICAL-c4364-db6e28f37a42955de4df14ff2555db9f462b03f0a91d33b2f7b73e4da212fbf53
IEDL.DBID	DRFUL
ISICitedReferencesCount	11
ISICitedReferencesURI	http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000267753700005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN	0269-4727 1365-2710
IngestDate	Thu Oct 02 06:19:59 EDT 2025 Mon Jul 21 06:02:09 EDT 2025 Mon Jul 21 09:16:42 EDT 2025 Tue Nov 18 22:38:28 EST 2025 Sat Nov 29 02:34:13 EST 2025 Wed Jan 22 16:47:57 EST 2025 Sun Sep 21 06:25:53 EDT 2025
IsPeerReviewed	true
IsScholarly	true
Issue	4
Keywords	clinical pharmacy Clinical management Health staff cholesterol management Chemist Physician Metabolic diseases Lipids Hyperlipemia Dyslipemia Cholesterol Hospital pharmacy
Language	English
License	http://doi.wiley.com/10.1002/tdm_license_1.1 CC BY 4.0
LinkModel	DirectLink
MergedId	FETCHMERGED-LOGICAL-c4364-db6e28f37a42955de4df14ff2555db9f462b03f0a91d33b2f7b73e4da212fbf53
Notes	istex:3A8E44FD82E0E74D2FC21A0CCEBD93328192BD4F ArticleID:JCPT1024 ark:/67375/WNG-F4BXN9DJ-1 At the time of this study, Ms. Amanda WM Li, Angela CY Chau and Carol SY Fan were students of the Master of Clinical Pharmacy Programme, School of Pharmacy, CUHK. ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 ObjectType-Undefined-3
PMID	19583673
PQID	67465251
PQPubID	23479
PageCount	8
ParticipantIDs	proquest_miscellaneous_67465251 pubmed_primary_19583673 pascalfrancis_primary_21984180 crossref_citationtrail_10_1111_j_1365_2710_2009_01024_x crossref_primary_10_1111_j_1365_2710_2009_01024_x wiley_primary_10_1111_j_1365_2710_2009_01024_x_JCPT1024 istex_primary_ark_67375_WNG_F4BXN9DJ_1
PublicationCentury	2000
PublicationDate	August 2009
PublicationDateYYYYMMDD	2009-08-01
PublicationDate_xml	– month: 08 year: 2009 text: August 2009
PublicationDecade	2000
PublicationPlace	Oxford, UK
PublicationPlace_xml	– name: Oxford, UK – name: Oxford – name: England
PublicationTitle	Journal of clinical pharmacy and therapeutics
PublicationTitleAlternate	J Clin Pharm Ther
PublicationYear	2009
Publisher	Blackwell Publishing Ltd Blackwell
Publisher_xml	– name: Blackwell Publishing Ltd – name: Blackwell
References	Bosmans JE, Brook OH, Hein PJ et al. (2007) Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants. Pharmacoeconomics, 25, 25-37. Wun YT, Tang JL, Chao DVK (2001) Evidence-based management of dyslipiaemia: Hong Kong family physicians' perspective. Hong Kong Practitioner, 23, 191-200. Bild DE, Detrano R, Peterson D et al. (2005) Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation, 111, 1313-1320. Lee VWY, Chan WK, Lam NLC et al. (2005) Cost of acute myocardial infarction in Hong Kong. Disease Management & Health Outcomes, 13, 281-285. Cohen MV, Byrne MJ, Levine B et al. (1991) Low rate of treatment of hypercholesterolemia by cardiologists in suspected and proven coronary artery diseases. Circulation, 83, 1294-1304. Faulkner MA, Wadibia EC, Lucas BD et al. (2000) Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy, 20, 410-416. Bogden PE, Koontz LM, Williamson P et al. (1997) The physician and pharmacist team: an effective approach to cholesterol reduction. Journal of General Internal Medicine, 12, 158-164. The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group (1998) Prevention of cardiovascular events and death with Pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. New England Journal of Medicine, 339: 1349-1357. Lee VWY, Chan WK, Lee BSC et al. (2008) Cholesterol goal attainment among coronary heart disease patients in Hong Kong. Value in Health, 11, S91-S98. Avorn J, Monnett J, Lacour A et al. (1998) Relationship between patient characteristics and high persistence. JAMA, 279, 1458-1462. Prochaska JO, Velicer WF (1997) The transtheoretical model of health behavior change. American Journal of Health Promotion, 12, 38-48. Clark PM, Karagoz T, Apikoglu-Rabus S et al. (2007) Effect of pharmacist-led patient education on adherence to tuberculosis treatment. American Journal of Health-System Pharmacy, 64, 497-506. Pang RW, Tam S, Janus ED et al. (2006) Plasma lipid, lipoprotein and apolipoprotein levels in a random population sample of 2875 Hong Kong Chinese adults and their implications (NCEP ATP-III, 2001 guidelines) on cardiovascular risk assessment. Atherosclerosis, 184, 438-445. Olson KL, Rasmussen J, Sandhoff BG et al. (2005) Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organization. Archives of Internal Medicine, 165, 49-54. Simpson RJ (2006) Challenges for improving medication adherence. Journal of American Medical Association, 296, 2614-2616. Benner JS, Glynn RJ, Mogun H et al. (2002) Long-term persistence in use of statin therapy in elderly patients. Journal of American Medical Association, 288, 455-461. LaRosa JH, LaRosa JC (2000) Enhancing drug compliance in lipid-lowering treatment. Archives of Family Medicine, 9, 1169-1175. Dole EJ, Murawski MM, Adikohe AB et al. (2007) Provision of pain management by a pharmacist with prescribing authority. American Journal of Health-System Pharmacy, 64, 85-89. Bluml BM, McKenney JM, Cziraky MJ (2000) Pharmaceutical care services and results in project IMPACT: hyperlipidaemia. Journal of American Pharmaceutical Association, 40, 157-165. Insull W (1997) The problem of compliance to cholesterol altering therapy. Journal of Internal Medicine, 241, 317-325. Lee SSC, Cheung PYP, Chow MSS (2004) Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong. Journal of Clinical Pharmacology, 44, 632-639. Elliott RA (2006) Poor adherence to anti-inflammatory medication in asthma: reasons, challenges, and strategies for improved disease management. Disease Management & Health Outcomes, 14, 223-233. Wu JYF, Leung WYS, Chang S et al. (2006) Effectiveness of telephone counseling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomized controlled trial. British Medical Journal, 333, 522. Bozovich M, Rubino CM, Edmunds J (2000) Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals. Pharmacotherapy, 20, 1375-1383. Grundy SM, Cleeman JI, Merz CNB et al. (2004) Implications of recent clinical trials for the National cholesterol Education Program Adult Treatment Panel III guidelines. Circulation, 110, 227-239. WHO (2004) Cardiovascular disease: prevention and control. Geneva: World health Organization. Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (2002) Third report of National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Final report (NCEP ATP - III). Circulation, 106, 3143-3418. 2004; 44 2005; 111 2000; 9 2006; 14 2000; 20 1998; 339 2006; 296 2004 2008; 11 1998; 279 20052006 2001; 23 2006; 333 2004; 110 2005; 165 1997; 241 1991; 83 2002; 288 1997; 12 2002; 106 2006; 184 2000; 40 2007; 64 2007; 25 2005; 13 Bogden (10.1111/j.1365-2710.2009.01024.x-BIB22) 1997; 12 Bild (10.1111/j.1365-2710.2009.01024.x-BIB4) 2005; 111 Lee (10.1111/j.1365-2710.2009.01024.x-BIB5) 2005; 13 LaRosa (10.1111/j.1365-2710.2009.01024.x-BIB16) 2000; 9 Bosmans (10.1111/j.1365-2710.2009.01024.x-BIB19) 2007; 25 Wun (10.1111/j.1365-2710.2009.01024.x-BIB6) 2001; 23 Cohen (10.1111/j.1365-2710.2009.01024.x-BIB12) 1991; 83 Insull (10.1111/j.1365-2710.2009.01024.x-BIB14) 1997; 241 WHO (10.1111/j.1365-2710.2009.01024.x-BIB1) 2004 10.1111/j.1365-2710.2009.01024.x-BIB3 The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group (10.1111/j.1365-2710.2009.01024.x-BIB7) 1998; 339 10.1111/j.1365-2710.2009.01024.x-BIB2 Benner (10.1111/j.1365-2710.2009.01024.x-BIB15) 2002; 288 Lee (10.1111/j.1365-2710.2009.01024.x-BIB24) 2004; 44 Clark (10.1111/j.1365-2710.2009.01024.x-BIB18) 2007; 64 Wu (10.1111/j.1365-2710.2009.01024.x-BIB29) 2006; 333 10.1111/j.1365-2710.2009.01024.x-BIB8 Olson (10.1111/j.1365-2710.2009.01024.x-BIB23) 2005; 165 Bozovich (10.1111/j.1365-2710.2009.01024.x-BIB25) 2000; 20 Avorn (10.1111/j.1365-2710.2009.01024.x-BIB27) 1998; 279 Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (10.1111/j.1365-2710.2009.01024.x-BIB9) 2002; 106 Grundy (10.1111/j.1365-2710.2009.01024.x-BIB11) 2004; 110 Prochaska (10.1111/j.1365-2710.2009.01024.x-BIB30) 1997; 12 Dole (10.1111/j.1365-2710.2009.01024.x-BIB20) 2007; 64 Simpson (10.1111/j.1365-2710.2009.01024.x-BIB17) 2006; 296 Lee (10.1111/j.1365-2710.2009.01024.x-BIB13) 2008; 11 Elliott (10.1111/j.1365-2710.2009.01024.x-BIB21) 2006; 14 Bluml (10.1111/j.1365-2710.2009.01024.x-BIB26) 2000; 40 Pang (10.1111/j.1365-2710.2009.01024.x-BIB10) 2006; 184 Faulkner (10.1111/j.1365-2710.2009.01024.x-BIB28) 2000; 20
References_xml	– reference: Olson KL, Rasmussen J, Sandhoff BG et al. (2005) Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organization. Archives of Internal Medicine, 165, 49-54. – reference: Cohen MV, Byrne MJ, Levine B et al. (1991) Low rate of treatment of hypercholesterolemia by cardiologists in suspected and proven coronary artery diseases. Circulation, 83, 1294-1304. – reference: Bild DE, Detrano R, Peterson D et al. (2005) Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation, 111, 1313-1320. – reference: Bozovich M, Rubino CM, Edmunds J (2000) Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals. Pharmacotherapy, 20, 1375-1383. – reference: Lee VWY, Chan WK, Lam NLC et al. (2005) Cost of acute myocardial infarction in Hong Kong. Disease Management & Health Outcomes, 13, 281-285. – reference: Simpson RJ (2006) Challenges for improving medication adherence. Journal of American Medical Association, 296, 2614-2616. – reference: WHO (2004) Cardiovascular disease: prevention and control. Geneva: World health Organization. – reference: Pang RW, Tam S, Janus ED et al. (2006) Plasma lipid, lipoprotein and apolipoprotein levels in a random population sample of 2875 Hong Kong Chinese adults and their implications (NCEP ATP-III, 2001 guidelines) on cardiovascular risk assessment. Atherosclerosis, 184, 438-445. – reference: Insull W (1997) The problem of compliance to cholesterol altering therapy. Journal of Internal Medicine, 241, 317-325. – reference: Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (2002) Third report of National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Final report (NCEP ATP - III). Circulation, 106, 3143-3418. – reference: Elliott RA (2006) Poor adherence to anti-inflammatory medication in asthma: reasons, challenges, and strategies for improved disease management. Disease Management & Health Outcomes, 14, 223-233. – reference: LaRosa JH, LaRosa JC (2000) Enhancing drug compliance in lipid-lowering treatment. Archives of Family Medicine, 9, 1169-1175. – reference: Grundy SM, Cleeman JI, Merz CNB et al. (2004) Implications of recent clinical trials for the National cholesterol Education Program Adult Treatment Panel III guidelines. Circulation, 110, 227-239. – reference: Wu JYF, Leung WYS, Chang S et al. (2006) Effectiveness of telephone counseling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomized controlled trial. British Medical Journal, 333, 522. – reference: Bosmans JE, Brook OH, Hein PJ et al. (2007) Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants. Pharmacoeconomics, 25, 25-37. – reference: Wun YT, Tang JL, Chao DVK (2001) Evidence-based management of dyslipiaemia: Hong Kong family physicians' perspective. Hong Kong Practitioner, 23, 191-200. – reference: Clark PM, Karagoz T, Apikoglu-Rabus S et al. (2007) Effect of pharmacist-led patient education on adherence to tuberculosis treatment. American Journal of Health-System Pharmacy, 64, 497-506. – reference: Bluml BM, McKenney JM, Cziraky MJ (2000) Pharmaceutical care services and results in project IMPACT: hyperlipidaemia. Journal of American Pharmaceutical Association, 40, 157-165. – reference: Lee SSC, Cheung PYP, Chow MSS (2004) Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong. Journal of Clinical Pharmacology, 44, 632-639. – reference: Avorn J, Monnett J, Lacour A et al. (1998) Relationship between patient characteristics and high persistence. JAMA, 279, 1458-1462. – reference: Dole EJ, Murawski MM, Adikohe AB et al. (2007) Provision of pain management by a pharmacist with prescribing authority. American Journal of Health-System Pharmacy, 64, 85-89. – reference: Faulkner MA, Wadibia EC, Lucas BD et al. (2000) Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial. Pharmacotherapy, 20, 410-416. – reference: Lee VWY, Chan WK, Lee BSC et al. (2008) Cholesterol goal attainment among coronary heart disease patients in Hong Kong. Value in Health, 11, S91-S98. – reference: The Long-Term Intervention with Pravastatin in Ischemic Disease (LIPID) Study Group (1998) Prevention of cardiovascular events and death with Pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. New England Journal of Medicine, 339: 1349-1357. – reference: Benner JS, Glynn RJ, Mogun H et al. (2002) Long-term persistence in use of statin therapy in elderly patients. Journal of American Medical Association, 288, 455-461. – reference: Prochaska JO, Velicer WF (1997) The transtheoretical model of health behavior change. American Journal of Health Promotion, 12, 38-48. – reference: Bogden PE, Koontz LM, Williamson P et al. (1997) The physician and pharmacist team: an effective approach to cholesterol reduction. Journal of General Internal Medicine, 12, 158-164. – volume: 13 start-page: 281 year: 2005 end-page: 285 article-title: Cost of acute myocardial infarction in Hong Kong publication-title: Disease Management & Health Outcomes – volume: 20 start-page: 410 year: 2000 end-page: 416 article-title: Impact of pharmacy counseling on compliance and effectiveness of combination lipid‐lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial publication-title: Pharmacotherapy – volume: 333 start-page: 522 year: 2006 article-title: Effectiveness of telephone counseling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomized controlled trial publication-title: British Medical Journal – year: 20052006 – volume: 165 start-page: 49 year: 2005 end-page: 54 article-title: Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organization publication-title: Archives of Internal Medicine – volume: 241 start-page: 317 year: 1997 end-page: 325 article-title: The problem of compliance to cholesterol altering therapy publication-title: Journal of Internal Medicine – volume: 23 start-page: 191 year: 2001 end-page: 200 article-title: Evidence‐based management of dyslipiaemia: Hong Kong family physicians’ perspective publication-title: Hong Kong Practitioner – volume: 64 start-page: 497 year: 2007 end-page: 506 article-title: Effect of pharmacist‐led patient education on adherence to tuberculosis treatment publication-title: American Journal of Health-System Pharmacy – volume: 296 start-page: 2614 year: 2006 end-page: 2616 article-title: Challenges for improving medication adherence publication-title: Journal of American Medical Association – volume: 11 start-page: S91 year: 2008 end-page: S98 article-title: Cholesterol goal attainment among coronary heart disease patients in Hong Kong publication-title: Value in Health – volume: 44 start-page: 632 year: 2004 end-page: 639 article-title: Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong publication-title: Journal of Clinical Pharmacology – volume: 25 start-page: 25 year: 2007 end-page: 37 article-title: Cost effectiveness of a pharmacy‐based coaching programme to improve adherence to antidepressants publication-title: Pharmacoeconomics – volume: 339 start-page: 1349 year: 1998 end-page: 1357 article-title: Prevention of cardiovascular events and death with Pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels publication-title: New England Journal of Medicine – volume: 184 start-page: 438 year: 2006 end-page: 445 article-title: Plasma lipid, lipoprotein and apolipoprotein levels in a random population sample of 2875 Hong Kong Chinese adults and their implications (NCEP ATP‐III, 2001 guidelines) on cardiovascular risk assessment publication-title: Atherosclerosis – volume: 9 start-page: 1169 year: 2000 end-page: 1175 article-title: Enhancing drug compliance in lipid‐lowering treatment publication-title: Archives of Family Medicine – volume: 279 start-page: 1458 year: 1998 end-page: 1462 article-title: Relationship between patient characteristics and high persistence publication-title: JAMA – volume: 111 start-page: 1313 year: 2005 end-page: 1320 article-title: Ethnic differences in coronary calcification: the Multi‐Ethnic Study of Atherosclerosis (MESA) publication-title: Circulation – volume: 20 start-page: 1375 year: 2000 end-page: 1383 article-title: Effect of a clinical pharmacist‐managed lipid clinic on achieving National Cholesterol Education Program low‐density lipoprotein goals publication-title: Pharmacotherapy – volume: 40 start-page: 157 year: 2000 end-page: 165 article-title: Pharmaceutical care services and results in project IMPACT: hyperlipidaemia publication-title: Journal of American Pharmaceutical Association – year: 2004 – volume: 12 start-page: 158 year: 1997 end-page: 164 article-title: The physician and pharmacist team: an effective approach to cholesterol reduction publication-title: Journal of General Internal Medicine – volume: 14 start-page: 223 year: 2006 end-page: 233 article-title: Poor adherence to anti‐inflammatory medication in asthma: reasons, challenges, and strategies for improved disease management publication-title: Disease Management & Health Outcomes – volume: 64 start-page: 85 year: 2007 end-page: 89 article-title: Provision of pain management by a pharmacist with prescribing authority publication-title: American Journal of Health-System Pharmacy – volume: 83 start-page: 1294 year: 1991 end-page: 1304 article-title: Low rate of treatment of hypercholesterolemia by cardiologists in suspected and proven coronary artery diseases publication-title: Circulation – volume: 288 start-page: 455 year: 2002 end-page: 461 article-title: Long‐term persistence in use of statin therapy in elderly patients publication-title: Journal of American Medical Association – volume: 12 start-page: 38 year: 1997 end-page: 48 article-title: The transtheoretical model of health behavior change publication-title: American Journal of Health Promotion – volume: 106 start-page: 3143 year: 2002 end-page: 3418 article-title: Third report of National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Final report (NCEP ATP – III) publication-title: Circulation – volume: 110 start-page: 227 year: 2004 end-page: 239 article-title: Implications of recent clinical trials for the National cholesterol Education Program Adult Treatment Panel III guidelines publication-title: Circulation – volume: 111 start-page: 1313 year: 2005 ident: 10.1111/j.1365-2710.2009.01024.x-BIB4 article-title: Ethnic differences in coronary calcification: the Multi-Ethnic Study of Atherosclerosis (MESA) publication-title: Circulation doi: 10.1161/01.CIR.0000157730.94423.4B – volume: 339 start-page: 1349 year: 1998 ident: 10.1111/j.1365-2710.2009.01024.x-BIB7 article-title: Prevention of cardiovascular events and death with Pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels publication-title: New England Journal of Medicine doi: 10.1056/NEJM199811053391902 – ident: 10.1111/j.1365-2710.2009.01024.x-BIB3 – volume: 23 start-page: 191 year: 2001 ident: 10.1111/j.1365-2710.2009.01024.x-BIB6 article-title: Evidence-based management of dyslipiaemia: Hong Kong family physicians’ perspective publication-title: Hong Kong Practitioner – volume: 20 start-page: 410 year: 2000 ident: 10.1111/j.1365-2710.2009.01024.x-BIB28 article-title: Impact of pharmacy counseling on compliance and effectiveness of combination lipid-lowering therapy in patients undergoing coronary artery revascularization: a randomized, controlled trial publication-title: Pharmacotherapy doi: 10.1592/phco.20.5.410.35048 – volume: 296 start-page: 2614 year: 2006 ident: 10.1111/j.1365-2710.2009.01024.x-BIB17 article-title: Challenges for improving medication adherence publication-title: Journal of American Medical Association doi: 10.1001/jama.296.21.jed60074 – volume: 288 start-page: 455 year: 2002 ident: 10.1111/j.1365-2710.2009.01024.x-BIB15 article-title: Long-term persistence in use of statin therapy in elderly patients publication-title: Journal of American Medical Association doi: 10.1001/jama.288.4.455 – volume: 165 start-page: 49 year: 2005 ident: 10.1111/j.1365-2710.2009.01024.x-BIB23 article-title: Lipid management in patients with coronary artery disease by a clinical pharmacy service in a group model health maintenance organization publication-title: Archives of Internal Medicine doi: 10.1001/archinte.165.1.49 – volume: 12 start-page: 38 year: 1997 ident: 10.1111/j.1365-2710.2009.01024.x-BIB30 article-title: The transtheoretical model of health behavior change publication-title: American Journal of Health Promotion doi: 10.4278/0890-1171-12.1.38 – volume-title: Cardiovascular disease: prevention and control year: 2004 ident: 10.1111/j.1365-2710.2009.01024.x-BIB1 – volume: 12 start-page: 158 year: 1997 ident: 10.1111/j.1365-2710.2009.01024.x-BIB22 article-title: The physician and pharmacist team: an effective approach to cholesterol reduction publication-title: Journal of General Internal Medicine – volume: 40 start-page: 157 year: 2000 ident: 10.1111/j.1365-2710.2009.01024.x-BIB26 article-title: Pharmaceutical care services and results in project IMPACT: hyperlipidaemia publication-title: Journal of American Pharmaceutical Association – volume: 13 start-page: 281 year: 2005 ident: 10.1111/j.1365-2710.2009.01024.x-BIB5 article-title: Cost of acute myocardial infarction in Hong Kong publication-title: Disease Management & Health Outcomes doi: 10.2165/00115677-200513040-00006 – volume: 83 start-page: 1294 year: 1991 ident: 10.1111/j.1365-2710.2009.01024.x-BIB12 article-title: Low rate of treatment of hypercholesterolemia by cardiologists in suspected and proven coronary artery diseases publication-title: Circulation doi: 10.1161/01.CIR.83.4.1294 – volume: 110 start-page: 227 year: 2004 ident: 10.1111/j.1365-2710.2009.01024.x-BIB11 article-title: Implications of recent clinical trials for the National cholesterol Education Program Adult Treatment Panel III guidelines publication-title: Circulation doi: 10.1161/01.CIR.0000133317.49796.0E – volume: 44 start-page: 632 year: 2004 ident: 10.1111/j.1365-2710.2009.01024.x-BIB24 article-title: Benefits of individualized counseling by the pharmacist on the treatment outcomes of hyperlipidemia in Hong Kong publication-title: Journal of Clinical Pharmacology doi: 10.1177/0091270004265364 – volume: 279 start-page: 1458 year: 1998 ident: 10.1111/j.1365-2710.2009.01024.x-BIB27 article-title: Relationship between patient characteristics and high persistence publication-title: JAMA doi: 10.1001/jama.279.18.1458 – volume: 9 start-page: 1169 year: 2000 ident: 10.1111/j.1365-2710.2009.01024.x-BIB16 article-title: Enhancing drug compliance in lipid-lowering treatment publication-title: Archives of Family Medicine doi: 10.1001/archfami.9.10.1169 – ident: 10.1111/j.1365-2710.2009.01024.x-BIB2 – volume: 184 start-page: 438 year: 2006 ident: 10.1111/j.1365-2710.2009.01024.x-BIB10 article-title: Plasma lipid, lipoprotein and apolipoprotein levels in a random population sample of 2875 Hong Kong Chinese adults and their implications (NCEP ATP-III, 2001 guidelines) on cardiovascular risk assessment publication-title: Atherosclerosis doi: 10.1016/j.atherosclerosis.2005.05.013 – ident: 10.1111/j.1365-2710.2009.01024.x-BIB8 – volume: 11 start-page: S91 year: 2008 ident: 10.1111/j.1365-2710.2009.01024.x-BIB13 article-title: Cholesterol goal attainment among coronary heart disease patients in Hong Kong publication-title: Value in Health doi: 10.1111/j.1524-4733.2008.00372.x – volume: 333 start-page: 522 year: 2006 ident: 10.1111/j.1365-2710.2009.01024.x-BIB29 article-title: Effectiveness of telephone counseling by a pharmacist in reducing mortality in patients receiving polypharmacy: randomized controlled trial publication-title: British Medical Journal doi: 10.1136/bmj.38905.447118.2F – volume: 14 start-page: 223 year: 2006 ident: 10.1111/j.1365-2710.2009.01024.x-BIB21 article-title: Poor adherence to anti-inflammatory medication in asthma: reasons, challenges, and strategies for improved disease management publication-title: Disease Management & Health Outcomes doi: 10.2165/00115677-200614040-00005 – volume: 64 start-page: 497 year: 2007 ident: 10.1111/j.1365-2710.2009.01024.x-BIB18 article-title: Effect of pharmacist-led patient education on adherence to tuberculosis treatment publication-title: American Journal of Health-System Pharmacy doi: 10.2146/ajhp050543 – volume: 106 start-page: 3143 year: 2002 ident: 10.1111/j.1365-2710.2009.01024.x-BIB9 article-title: Third report of National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation and Treatment of High Blood Cholesterol in Adults. Final report (NCEP ATP - III) publication-title: Circulation doi: 10.1161/circ.106.25.3143 – volume: 241 start-page: 317 year: 1997 ident: 10.1111/j.1365-2710.2009.01024.x-BIB14 article-title: The problem of compliance to cholesterol altering therapy publication-title: Journal of Internal Medicine doi: 10.1046/j.1365-2796.1997.112133000.x – volume: 20 start-page: 1375 year: 2000 ident: 10.1111/j.1365-2710.2009.01024.x-BIB25 article-title: Effect of a clinical pharmacist-managed lipid clinic on achieving National Cholesterol Education Program low-density lipoprotein goals publication-title: Pharmacotherapy doi: 10.1592/phco.20.17.1375.34895 – volume: 64 start-page: 85 year: 2007 ident: 10.1111/j.1365-2710.2009.01024.x-BIB20 article-title: Provision of pain management by a pharmacist with prescribing authority publication-title: American Journal of Health-System Pharmacy doi: 10.2146/ajhp060056 – volume: 25 start-page: 25 year: 2007 ident: 10.1111/j.1365-2710.2009.01024.x-BIB19 article-title: Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants publication-title: Pharmacoeconomics doi: 10.2165/00019053-200725010-00004
SSID	ssj0006723
Score	1.9129502
Snippet	Summary Objective: The study aimed to investigate the clinical impact of pharmacist–physician co‐managed programme on the management of hyperlipidaemia.... The study aimed to investigate the clinical impact of pharmacist-physician co-managed programme on the management of hyperlipidaemia. The study was a... The study aimed to investigate the clinical impact of pharmacist-physician co-managed programme on the management of hyperlipidaemia.OBJECTIVEThe study aimed...
SourceID	proquest pubmed pascalfrancis crossref wiley istex
SourceType	Aggregation Database Index Database Enrichment Source Publisher
StartPage	407
SubjectTerms	Aged Biological and medical sciences Cholesterol - blood cholesterol management Cholesterol, LDL - blood Cholesterol, LDL - drug effects clinical pharmacy Disorders of blood lipids. Hyperlipoproteinemia Female Follow-Up Studies Hong Kong Humans Hyperlipidemias - drug therapy Hypolipidemic Agents - therapeutic use Interprofessional Relations Life Style Male Medical sciences Metabolic diseases Middle Aged Pharmaceutical Services - organization & administration Pharmacists - organization & administration Pharmacology. Drug treatments Physicians - organization & administration Professional Role Prospective Studies Single-Blind Method
Title	Clinical impact of a pharmacist-physician co-managed programme on hyperlipidaemia management in Hong Kong
URI	https://api.istex.fr/ark:/67375/WNG-F4BXN9DJ-1/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1365-2710.2009.01024.x https://www.ncbi.nlm.nih.gov/pubmed/19583673 https://www.proquest.com/docview/67465251
Volume	34
WOSCitedRecordID	wos000267753700005&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText	1
inHoldings	1
isFullTextHit
isPrint
journalDatabaseRights	– providerCode: PRVWIB databaseName: Wiley Online Library Full Collection 2020 customDbUrl: eissn: 1365-2710 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0006723 issn: 0269-4727 databaseCode: DRFUL dateStart: 19970101 isFulltext: true titleUrlDefault: https://onlinelibrary.wiley.com providerName: Wiley-Blackwell
link	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZglwOX8obwWHxAe2pQHDuvI7QsVUGrFdqKvVl2bJeI3WS1aav21p-AxD_sL2Ecp1ki9VAhLlEOGccez3hm7M8zCL3LFZU0jbQv8jCzSbVzX5JY-YkKlFSE5FKJpthEMp2mi0U2a_FP9i6Myw_RbbhZzWjWa6vgQtZ9JXf3qSyauUk7CbaSvQd_chiCGLMBGu5_mxx97dblOGmKvUHQAZ0Cs93H9dzYVs9YDS3fzy14UtTAP-MKX9zkmfYd3cZSTR78zzE-RDutv4o_OAF7hO7o8jEaz1zC64tdPN_e36p38RjPtqmwL56gVZt2dIndbUxcGSzw2n0DA726_N1treC8urr85dC0Cre4sZXGVYl_QLC8WRbrQgm9KgRedZgdXJT4oCqP8Rd4PEVHk0_zvQO_LfDg54zGzFcy1mFqaCLAKkaR0kwZwoyBMCdSMjMsDmVATSAyoiiVoUlkQuEjAfbWSBPRZ2hQVqV-gXAcMgPRrYCpj5jIjMwDE0D0nRItTEiVh5LrmeR5m_3cFuFY8r-iIOA1t7y2tTkz3vCan3uIdJRrlwHkFjTjRlg6ArH5aRF0ScS_Tz_zCfu4mGb7h5x4aNSTpo4ADEnKSBp46O21eHFQfHuaI0pdndbQHIsj8E499NxJ3bZ3WZRS-BuMuRGuW3ebH-7N5vb15T9TvkL33XmbhUi-RoOTzal-g-7lZydFvRmhu8kiHbWK-Qdekjak
linkProvider	Wiley-Blackwell
linkToHtml	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtQwELbQbiW4AOU3QFsf0J4alMTO3xFatku7RCu0FXuz7NiGiN1ktdui9tZHQOIN-ySM4zRLpB4qxCXKwePYkxnPjP15BqG3uSSCJKFyeR6kJql27go_km4sPSmk7-dC8rrYRJxlyWyWTppyQOYujM0P0W64Gc2o12uj4GZDuqvl9kKVgTPXeSfBWNJ34FD2KUhV2EP9wy_D03G7MEdxXe0Nog4YFdjtLrDn1r461qpvGH9h0JN8DQzUtvLFba5p19OtTdXw0X-d5GP0sPFY8XsrYtvoniqfoMHEpry-3MfTzQ2u9T4e4MkmGfblU7RoEo_Osb2PiSuNOV7aNjDT66vf7eYKzqvrq18WTytxgxxbKFyV-DuEy6t5sSwkV4uC40WL2sFFiUdV-Q2fwOMZOh1-nB6M3KbEg5tTElFXikgFiSYxB7sYhlJRqX2qNQQ6oRSpplEgPKI9nvqSEBHoWMQEGnGwuFrokDxHvbIq1UuEo4BqiG95EIMXylMtck97EH8nvuI6INJB8c2vZHmT_9yU4Zizv-Ig4DUzvDbVOVNW85pdOMhvKZc2B8gdaAa1tLQEfPXDYOjikH3NjtiQfphl6eEx8x202xGnlgBMSUL9xHPQ3o18MVB9c57DS1Wdr6E7GoXgnzrohRW7zejSMCHwNZhzLV13HjY7PphMzeurf6bcQ_dH089jNv6UnbxGD-zpmwFMvkG9s9W52kFb-c-zYr3abfTzD6RbOaw
linkToPdf	http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELZQFyEuvB_h0fqA9tSgJHZeR-gSSltFEdqKvVl2bJeI3WS126L21p-AxD_sL2Ecp1ki9VAhLlEOHseezHhm7M8zCL0rJREkCZXLyyA1SbVLV_iRdGPpSSF9vxSSt8Um4jxPZrO06MoBmbswNj9Ev-FmNKNdr42Cq6XUQy23F6oMnLnNOwnGkr4Hh3JEwzQCLR1NvmbHR_3CHMVttTeIOmBUYLeHwJ4b-xpYq5Fh_LlBT_I1MFDbyhc3uaZDT7c1VdnD_zrJR-hB57HiD1bEHqM7qn6CxoVNeX2xi6ebG1zrXTzGxSYZ9sVTtOgSj86xvY-JG405Xto2MNOry9_95goum6vLXxZPK3GHHFso3NT4O4TLq3m1rCRXi4rjRY_awVWN95v6BB_C4xk6zj5N9_bdrsSDW1ISUVeKSAWJJjEHuxiGUlGpfao1BDqhFKmmUSA8oj2e-pIQEehYxAQacbC4WuiQPEdbdVOrlwhHAdUQ3_IgBi-Up1qUnvYg_k58xXVApIPi61_Jyi7_uSnDMWd_xUHAa2Z4bapzpqzlNTt3kN9TLm0OkFvQjFtp6Qn46ofB0MUh-5Z_Zhn9OMvTyQHzHbQ9EKeeAExJQv3Ec9DOtXwxUH1znsNr1ZytoTsaheCfOuiFFbvN6NIwIfA1mHMrXbceNjvYK6bm9dU_U-6ge8UkY0df8sPX6L49fDN4yTdo63R1pt6iu-XP02q92u7U8w_adDkn
openUrl	ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Clinical+impact+of+a+pharmacist-physician+co-managed+programme+on+hyperlipidaemia+management+in+Hong+Kong&rft.jtitle=Journal+of+clinical+pharmacy+and+therapeutics&rft.au=Lee%2C+V+W+Y&rft.au=Fan%2C+C+S+Y&rft.au=Li%2C+A+W+M&rft.au=Chau%2C+A+C+Y&rft.date=2009-08-01&rft.issn=1365-2710&rft.eissn=1365-2710&rft.volume=34&rft.issue=4&rft.spage=407&rft_id=info:doi/10.1111%2Fj.1365-2710.2009.01024.x&rft.externalDBID=NO_FULL_TEXT
thumbnail_l	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0269-4727&client=summon
thumbnail_m	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0269-4727&client=summon
thumbnail_s	http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0269-4727&client=summon